AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16311044 — intervention group
Group type: EXPERIMENTAL
Intervention: Trunk muscles
Number of subjects: 23
Study 16311044 — intervention group
Group type: EXPERIMENTAL
Intervention: Thigh muscles
Number of subjects: 23
Study 16311044 — intervention group
Group type: EXPERIMENTAL
Intervention: Soleus and gastrocnemius muscles
Number of subjects: 23
Study 16311044 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of periodicity between soleus and gastrocnemius
Number of subjects: 23
Study 12727703 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior self-help
Number of subjects: 85
Study 12727703 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonspecific self-help
Number of subjects: 85
Study 12727703 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 85
Study 10799795 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac epolamine patch applied twice daily for 2 weeks
Number of subjects: 222
Study 10799795 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch applied twice daily for 2 weeks
Number of subjects: 222
Study 8582495 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 24
Study 8582495 — intervention group
Group type: COMPARATOR
Intervention: Pindolol
Number of subjects: 24
Study 2212207 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental teeth with orthodontic band allowing plaque accumulation for 1 day
Number of subjects: 11
Study 2212207 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental teeth with orthodontic band allowing plaque accumulation for 2 days
Number of subjects: 11
Study 2212207 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental teeth with orthodontic band allowing plaque accumulation for 4 days
Number of subjects: 11
Study 2212207 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental teeth with orthodontic band allowing plaque accumulation for 8 days
Number of subjects: 11
Study 2212207 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental teeth with orthodontic band allowing plaque accumulation for 14 days
Number of subjects: 11
Study 352183 — intervention group
Group type: EXPERIMENTAL
Intervention: Etomidate
Number of subjects: 0
Study 352183 — intervention group
Group type: COMPARATOR
Intervention: Methohexitone
Number of subjects: 0
Study 31172116 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized budesonide
Number of subjects: 41
Study 31172116 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 41
Study 27671372 — intervention group
Group type: EXPERIMENTAL
Intervention: The Canary System
Number of subjects: 105
Study 27671372 — intervention group
Group type: EXPERIMENTAL
Intervention: DIAGNOdent
Number of subjects: 105
Study 26394017 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus telemedicine (n=24)
Number of subjects: 50
Study 26394017 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n=26)
Number of subjects: 50
Study 23224717 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective reporting of antibiotic susceptibility data (2 to 4 antibiotics only)
Number of subjects: 326
Study 23224717 — intervention group
Group type: COMPARATOR
Intervention: Usual full-length reporting of antibiotic susceptibility data (25 antibiotics)
Number of subjects: 326
Study 23224717 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective reporting of antibiotic susceptibility data
Number of subjects: 326
Study 23224717 — intervention group
Group type: COMPARATOR
Intervention: Usual full-length reporting of antibiotic susceptibility data
Number of subjects: 326
Study 22010525 — intervention group
Group type: EXPERIMENTAL
Intervention: Earlier rescue group (rescue ICSI performed between 4 and 6 hours after insemination)
Number of subjects: 112
Study 18280940 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyglycolic acid sutures
Number of subjects: 55
Study 18280940 — intervention group
Group type: COMPARATOR
Intervention: Silk sutures
Number of subjects: 55
Study 18280940 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine solution
Number of subjects: 55
Study 17268121 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated hsCRP level
Number of subjects: 823
Study 17268121 — intervention group
Group type: EXPERIMENTAL
Intervention: Low CVrr (below the 5 percentile)
Number of subjects: 823
Study 12673748 — intervention group
Group type: EXPERIMENTAL
Intervention: Local quality assurance system at Uppsala University Hospital (UUH)
Number of subjects: 0
Study 12673748 — intervention group
Group type: COMPARATOR
Intervention: National Board of Health and Welfare (NBH) register
Number of subjects: 0
Study 12673748 — intervention group
Group type: COMPARATOR
Intervention: Regional Oncological Centres (ROC) register
Number of subjects: 0
Study 11118018 — intervention group
Group type: EXPERIMENTAL
Intervention: NPH insulin
Number of subjects: 20
Study 11118018 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous infusion of insulin lispro (CSII)
Number of subjects: 20
Study 11118018 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultralente human insulin
Number of subjects: 20
Study 11118018 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting insulin analog glargine
Number of subjects: 20
Study 9007918 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical fluocinolone acetonide 0.1%
Number of subjects: 33
Study 9007918 — intervention group
Group type: COMPARATOR
Intervention: Topical retinoic acid 0.05%
Number of subjects: 33
Study 8117604 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (cisplatin 100 mg/m2 on day 1 and etoposide 120 mg/m2 on days 1, 2, 3 every 3 weeks for 3 courses followed by radiotherapy 56 Gy on pre-treatment tumor volume and 40 Gy on mediastinum and bilateral supraclavicular nodes)
Number of subjects: 66
Study 8117604 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone (40 Gy on mediastinum and bilateral supraclavicular nodes)
Number of subjects: 66
Study 3086849 — intervention group
Group type: EXPERIMENTAL
Intervention: Patch A
Number of subjects: 30
Study 3086849 — intervention group
Group type: EXPERIMENTAL
Intervention: Patch B
Number of subjects: 30
Study 3086849 — intervention group
Group type: EXPERIMENTAL
Intervention: Patch C
Number of subjects: 30
Study 3086849 — intervention group
Group type: COMPARATOR
Intervention: Comparison between patches A and B
Number of subjects: 30
Study 30961367 — intervention group
Group type: EXPERIMENTAL
Intervention: New cotton-enhanced diaper
Number of subjects: 131
Study 30961367 — intervention group
Group type: COMPARATOR
Intervention: Existing natural diaper
Number of subjects: 131
Study 29921291 — intervention group
Group type: EXPERIMENTAL
Intervention: Endorectal Balloon (ERB)
Number of subjects: 10
Study 29921291 — intervention group
Group type: COMPARATOR
Intervention: No Endorectal Balloon (ERB)
Number of subjects: 10
Study 27102981 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol 800μg
Number of subjects: 18
Study 27102981 — intervention group
Group type: EXPERIMENTAL
Intervention: Buccal misoprostol 800μg
Number of subjects: 18
Study 27102981 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral misoprostol 800μg
Number of subjects: 18
Study 27102981 — intervention group
Group type: COMPARATOR
Intervention: All routes of administration
Number of subjects: 18
Study 25069975 — intervention group
Group type: EXPERIMENTAL
Intervention: mRDTs introduced in drug shops
Number of subjects: 0
Study 22504283 — intervention group
Group type: EXPERIMENTAL
Intervention: Chef Initiative schools (healthier school lunches prepared by a professional chef)
Number of subjects: 2
Study 22504283 — intervention group
Group type: COMPARATOR
Intervention: Control schools (standard school lunches)
Number of subjects: 2
Study 20429831 — intervention group
Group type: EXPERIMENTAL
Intervention: EC-ASA 81 mg once daily alone
Number of subjects: 47
Study 20429831 — intervention group
Group type: EXPERIMENTAL
Intervention: EC-ASA 81 mg once daily with acetaminophen 1 g four times daily
Number of subjects: 47
Study 20429831 — intervention group
Group type: EXPERIMENTAL
Intervention: EC-ASA 81 mg once daily with NAPSO 220 mg three times daily
Number of subjects: 47
Study 18467930 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythmic auditory stimulation at normal tempo
Number of subjects: 17
Study 18467930 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythmic auditory stimulation at fast tempo
Number of subjects: 17
Study 18467930 — intervention group
Group type: COMPARATOR
Intervention: Normal walking without rhythm
Number of subjects: 17
Study 18467930 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking as fast as safely possible without auditory rhythm
Number of subjects: 17
Study 18467930 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythmic auditory stimulation set 5% higher than fast walk
Number of subjects: 17
Study 15939585 — intervention group
Group type: EXPERIMENTAL
Intervention: Third-generation non-steroidal aromatase inhibitors (NS-AIs) anastrozole and letrozole
Number of subjects: 0
Study 15939585 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroidal aromatase inhibitor (S-AI) exemestane
Number of subjects: 0
Study 15939585 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 0
Study 15939585 — intervention group
Group type: COMPARATOR
Intervention: Megestrol acetate
Number of subjects: 0
Study 12442882 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil 5 mg/day for the first 28 days and 10 mg/day thereafter (n = 102)
Number of subjects: 207
Study 12442882 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil (n = 102)
Number of subjects: 207
Study 12442882 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 105)
Number of subjects: 207
Study 10442786 — intervention group
Group type: COMPARATOR
Intervention: Various treatments in psychiatry
Number of subjects: 0
Study 10442786 — intervention group
Group type: EXPERIMENTAL
Intervention: Proven treatments applied by psychiatrists
Number of subjects: 0
Study 10442786 — intervention group
Group type: EXPERIMENTAL
Intervention: Health budget segmentation
Number of subjects: 0
Study 8734751 — intervention group
Group type: EXPERIMENTAL
Intervention: Sintered platinum leads
Number of subjects: 99
Study 8734751 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated pyrolytic carbon leads
Number of subjects: 99
Study 8734751 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitreous carbon leads
Number of subjects: 99
Study 8734751 — intervention group
Group type: COMPARATOR
Intervention: All lead types
Number of subjects: 99
Study 1632690 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiation therapy and surgery
Number of subjects: 148
Study 1632690 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 148
Study 1632690 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiation therapy and surgery (subset of 56 patients with locally advanced lesions)
Number of subjects: 148
Study 6371695 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention involving a standardized interview and a printed information sheet for reinforcement 2 months later.
Number of subjects: 108
Study 6371695 — intervention group
Group type: COMPARATOR
Intervention: Control group (details not specified).
Number of subjects: 108
Study 30914312 — intervention group
Group type: EXPERIMENTAL
Intervention: 19-G EBUS needle
Number of subjects: 107
Study 30914312 — intervention group
Group type: COMPARATOR
Intervention: 22-G EBUS needle
Number of subjects: 107
Study 28554173 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus 10 mg/day
Number of subjects: 302
Study 28554173 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 302
Study 27837934 — intervention group
Group type: EXPERIMENTAL
Intervention: Selumetinib 75 mg
Number of subjects: 54
Study 27837934 — intervention group
Group type: EXPERIMENTAL
Intervention: Selumetinib 150 mg (predicted)
Number of subjects: 54
Study 27837934 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 27837934 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin (positive control)
Number of subjects: 54
Study 24840317 — intervention group
Group type: EXPERIMENTAL
Intervention: INSULIN‐PH20
Number of subjects: 46
Study 24840317 — intervention group
Group type: COMPARATOR
Intervention: Insulin lispro
Number of subjects: 46
Study 22506468 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedicled sternocleidomastoid muscle flap
Number of subjects: 73
Study 22506468 — intervention group
Group type: COMPARATOR
Intervention: Direct suture (control)
Number of subjects: 73
Study 22506468 — intervention group
Group type: COMPARATOR
Intervention: Comparison between flap and control groups
Number of subjects: 73
Study 20384591 — intervention group
Group type: EXPERIMENTAL
Intervention: MSICS
Number of subjects: 224
Study 20384591 — intervention group
Group type: COMPARATOR
Intervention: Phacoemulsification
Number of subjects: 224
Study 18320064 — intervention group
Group type: COMPARATOR
Intervention: CPG-DDS alone
Number of subjects: 223
Study 18320064 — intervention group
Group type: EXPERIMENTAL
Intervention: CPG-DDS + artesunate 1 mg/kg
Number of subjects: 223
Study 18320064 — intervention group
Group type: EXPERIMENTAL
Intervention: CPG-DDS + artesunate 2 mg/kg
Number of subjects: 223
Study 18320064 — intervention group
Group type: EXPERIMENTAL
Intervention: CPG-DDS + artesunate 4 mg/kg
Number of subjects: 223
Study 18320064 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment emergent adverse events
Number of subjects: 223
Study 18320064 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious adverse events
Number of subjects: 223
Study 15797592 — intervention group
Group type: EXPERIMENTAL
Intervention: Base method debonding
Number of subjects: 50
Study 15797592 — intervention group
Group type: COMPARATOR
Intervention: Wings method debonding
Number of subjects: 50
Study 15797592 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 50
Study 12455076 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mm long Scimed Cobra balloon followed by focal stenting
Number of subjects: 41
Study 12455076 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mm long Scimed Cobra balloon followed by focal stenting
Number of subjects: 41
Study 10874989 — intervention group
Group type: EXPERIMENTAL
Intervention: Cord blood IL-6 levels in infants of mothers considered to be noninfected
Number of subjects: 17
Study 10874989 — intervention group
Group type: COMPARATOR
Intervention: Maternal blood IL-6 levels
Number of subjects: 17
Study 10874989 — intervention group
Group type: COMPARATOR
Intervention: Peripheral infant blood IL-6 levels
Number of subjects: 17
Study 10874989 — intervention group
Group type: COMPARATOR
Intervention: Clinical symptoms of infants
Number of subjects: 17
Study 10874989 — intervention group
Group type: COMPARATOR
Intervention: Maternal prepartum treatment with antibiotics and/or steroids
Number of subjects: 17
Study 10874989 — intervention group
Group type: COMPARATOR
Intervention: Low infant blood IL-6 level
Number of subjects: 17
Study 8609325 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibutilide (0.005 to 0.025 mg/kg body weight)
Number of subjects: 35
Study 8609325 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 8609325 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibutilide (nonconverters)
Number of subjects: 35
Study 1930840 — intervention group
Group type: EXPERIMENTAL
Intervention: Pumice prophylaxis with a rubber cup and slow‐speed handpiece
Number of subjects: 45
Study 1930840 — intervention group
Group type: COMPARATOR
Intervention: Conventional fluoridated dentifrice (Colgate)
Number of subjects: 45
Study 1930840 — intervention group
Group type: EXPERIMENTAL
Intervention: Triclosan/copolymer/NaF dentifrice (Colgate)
Number of subjects: 45
Study 7295460 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbitone 80 mg
Number of subjects: 24
Study 7295460 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbitone 140 mg
Number of subjects: 24
Study 7295460 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbitone 240 mg
Number of subjects: 24
Study 7295460 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 7295460 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbitone (all doses)
Number of subjects: 24
Study 31054246 — intervention group
Group type: EXPERIMENTAL
Intervention: Palmitoylethanolamide (PEA)
Number of subjects: 0
Study 31054246 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD)
Number of subjects: 0
Study 31054246 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 0
Study 29026123 — intervention group
Group type: EXPERIMENTAL
Intervention: Happy mood induced by listening to music excerpts for about 10 minutes
Number of subjects: 0
Study 29026123 — intervention group
Group type: COMPARATOR
Intervention: Sad mood induced by listening to music excerpts for about 10 minutes
Number of subjects: 0
Study 27734108 — intervention group
Group type: EXPERIMENTAL
Intervention: 3M™ IV Advanced dressing
Number of subjects: 628
Study 27734108 — intervention group
Group type: COMPARATOR
Intervention: Hospital's classical transparent dressing
Number of subjects: 628
Study 24842062 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial bone preparation followed by a 2-week delay before implant placement
Number of subjects: 12
Study 24842062 — intervention group
Group type: COMPARATOR
Intervention: Conventional protocol
Number of subjects: 12
Study 22527786 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg intravenously
Number of subjects: 372
Study 22527786 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 372
Study 21400763 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment for cruciate ligament injury
Number of subjects: 16
Study 17608975 — intervention group
Group type: EXPERIMENTAL
Intervention: Videolaryngoscope
Number of subjects: 80
Study 17608975 — intervention group
Group type: COMPARATOR
Intervention: Direct vision (Control)
Number of subjects: 80
Study 16306834 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-segment (SS) pedicle fixation
Number of subjects: 18
Study 16306834 — intervention group
Group type: COMPARATOR
Intervention: Long-segment (LS) instrumentation
Number of subjects: 18
Study 12487321 — intervention group
Group type: EXPERIMENTAL
Intervention: Camphor-Crataegus berry combination (CCC) - 5 drops
Number of subjects: 48
Study 12487321 — intervention group
Group type: EXPERIMENTAL
Intervention: Camphor-Crataegus berry combination (CCC) - 20 drops
Number of subjects: 48
Study 12487321 — intervention group
Group type: EXPERIMENTAL
Intervention: Camphor-Crataegus berry combination (CCC) - 80 drops
Number of subjects: 48
Study 12487321 — intervention group
Group type: COMPARATOR
Intervention: Placebo (20 drops of a 60% alcoholic solution)
Number of subjects: 48
Study 9583346 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 77
Study 9583346 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 77
Study 9583346 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic plus strength training combined
Number of subjects: 77
Study 9583346 — intervention group
Group type: COMPARATOR
Intervention: No exercise (control group)
Number of subjects: 77
Study 9583346 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular exercise in the 4 months preceding follow-up
Number of subjects: 77
Study 8130051 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane-nitrous oxide (n = 10) at concentrations of 1.5-1.95 MAC
Number of subjects: 20
Study 8130051 — intervention group
Group type: COMPARATOR
Intervention: Halothane-nitrous oxide (n = 10) at concentrations of 1.5-1.95 MAC
Number of subjects: 20
Study 8130051 — intervention group
Group type: COMPARATOR
Intervention: Comparison of isoflurane-nitrous oxide and halothane-nitrous oxide
Number of subjects: 20
Study 8130051 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane-nitrous oxide and halothane-nitrous oxide at equiMAC concentrations
Number of subjects: 20
Study 2658793 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-beta-lactam group (netilmicin plus piperacillin or azlocillin)
Number of subjects: 174
Study 2658793 — intervention group
Group type: COMPARATOR
Intervention: Single-beta-lactam group (ceftazidime plus piperacillin or azlocillin)
Number of subjects: 174
Study 2658793 — intervention group
Group type: COMPARATOR
Intervention: Single-beta-lactam combination
Number of subjects: 174
Study 2658793 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-beta-lactam group
Number of subjects: 174
Study 31895303 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangaroo mother care (n = 30), provided twice a day until discharge
Number of subjects: 60
Study 31895303 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 30), routine application only
Number of subjects: 60
Study 31895303 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangaroo mother care (n = 30)
Number of subjects: 60
Study 29050753 — intervention group
Group type: EXPERIMENTAL
Intervention: Spray Cryotherapy (SCT)
Number of subjects: 40
Study 29050753 — intervention group
Group type: COMPARATOR
Intervention: Placebo (without SCT)
Number of subjects: 40
Study 26086183 — intervention group
Group type: EXPERIMENTAL
Intervention: NBP 200 mg three times daily
Number of subjects: 281
Study 26086183 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 281
Study 26247144 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical-CPR
Number of subjects: 2589
Study 26247144 — intervention group
Group type: COMPARATOR
Intervention: Manual-CPR
Number of subjects: 2589
Study 22772956 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-level intervention to prevent childhood obesity
Number of subjects: 221
Study 20361860 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity patient simulation (including face-to-face instruction)
Number of subjects: 20
Study 20361860 — intervention group
Group type: COMPARATOR
Intervention: Online, narrated PowerPoint presentation
Number of subjects: 20
Study 18586530 — intervention group
Group type: EXPERIMENTAL
Intervention: Cement pressurization technique with pegged glenoid component
Number of subjects: 81
Study 16630205 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 2
Study 16630205 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 2
Study 12818310 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL/HDL ratio
Number of subjects: 0
Study 12818310 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL levels
Number of subjects: 0
Study 12818310 — intervention group
Group type: EXPERIMENTAL
Intervention: TC/HDL ratio
Number of subjects: 0